Healthcare/Pharmaceuticals Analysts discuss relevant multi-cancer early detection tests (relevant companies EXAS, GH and GRAL) on an Analyst/Industry conference call to be held on September 30 at 11 am.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Exact Sciences management to meet with Craig-Hallum
- Exact Sciences price target raised to $85 from $65 at Craig-Hallum
- Exact Sciences launches Cancerguard test in the U.S.
- Promising Growth Prospects for Exact Sciences: Buy Rating Justified by Strong Cologuard Performance and Strategic Initiatives
- Cathie Wood Buys Deere Stock (DE) on Post-Earnings Dip, Builds Stakes in Exact Sciences and Robinhood Stocks